Caraco Pharmaceutical Laboratories, Ltd. (CPD)

[surf1944]

Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride Injection
Press Release
Source: Caraco Pharmaceutical Laboratories, Ltd.
On 10:20 am EST, Wednesday November 18, 2009

Companies:Caraco Pharmaceutical Laboratories Ltd.
DETROIT, Nov. 18 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched Nicardipine Hydrochloride Injection immediately following Sun Pharma's final approval from the US Food and Drug Administration (FDA). Nicardipine Hydrochloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. These Nicardipine Hydrochloride Injections are available as 25 mg/10ml single use ampuls containing 2.5 mg/ml of the drug, and have annual sales of approximately USD 170 million in the US.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.